Stephens & Co. Maintains Equal-Weight on Ovintiv, Lowers Price Target to $68

Benzinga Newsdesk www.benzinga.com Neutral 70.7%

Neg 0% Neu 70.7% Pos 0%

Stephens & Co. analyst Mike Scialla maintains Ovintiv (NYSE:OVV) with a Equal-Weight and lowers the price target from $71 to $68.